EU GMP Annex 1 — Manufacture of Sterile Medicinal Products (revised)
Applies: 25 August 2023 (the lyophilisation provision at 8.123 applied from 25 August 2024)
The revision reorganised sterile requirements around quality risk management and a documented contamination control strategy. The most common gap is a CCS assembled by cross-referencing existing SOPs rather than written as a site-level strategy with evidence of effectiveness.
